Diginex's Growth Engine Runs on New Shares — and Existing Holders Are Paying the Tab

Diginex's all-paper $1.05B Resulticks acquisition dilutes current shareholders to 14%, as losses widen and stock slides 23% in seven days.

The math behind Diginex's expansion strategy is brutally simple: a company with 114 employees is buying one that will control 86 percent of the combined group. For current shareholders, that arithmetic translates into a stake worth just 14 percent of whatever emerges from the Resulticks Global Companies acquisition — a 1.05 billion US-Dollar, all-paper deal signed last Friday and paid for with 600 million new Diginex shares priced at 1.75 dollars each.

The market has already delivered its verdict on the terms. The stock has shed roughly 5.9 percent since the amended purchase agreement was inked, extending a seven-day slide that now stands at 23 percent. Over a 30-day horizon, the shares have managed only a modest 1.7 percent gain, while annualized volatility of 115 percent underscores just how jittery trading has become with each twist in the Resulticks saga.

A Transformative Year — But Whose Transformation?

Diginex itself branded the fiscal year ending in March as "transformative," and the label is hard to dispute on the surface. Revenue jumped 77 percent to 3.6 million dollars, propelled by the acquisitions of Plan A, Matter, and The Remedy Project. Headcount more than tripled from 32 to 114, though 79 of those 82 new positions arrived through the purchased businesses rather than organic hiring.

The underlying picture is considerably less flattering. The net loss ballooned to 31.1 million dollars — up from 5.2 million the prior year — while adjusted EBITDA came in at negative 13.0 million dollars. The damage was driven by higher personnel costs, M&A-related expenses, and a 7.0 million-dollar goodwill impairment tied to the Matter acquisition. On the balance sheet, the company remains debt-free with 4.9 million dollars in cash — a cushion that would barely cover a single year of losses at this pace without fresh capital.

That capital arrived in August, and it came with strings attached. Diginex announced a 20.0 million-dollar capital raise comprising 20.0 million new common shares plus five-year warrants for another 20.0 million shares at an exercise price of 1.00 dollar. This sits alongside 70 million dollars in private financing commitments secured for the combined entity — 20 million of which will flow into Diginex's own balance sheet, with 50 million earmarked for the Resulticks acquisition.

The warrant mechanics are worth scrutiny. With the exercise price set at 1.00 dollar and the stock trading near 1.25 dollars, warrant holders have every incentive to convert on any upward move, further inflating the share count. It's a dilution machine that keeps feeding itself.

A Reverse Takeover in All But Name

The October 8 extraordinary general meeting will settle the crucial questions: approval of the Resulticks acquisition, an increase in authorized share capital, and adoption of new articles of association. If the deal closes as scheduled by October 30, Redickaa Subrammanian — Resulticks' co-founder and CEO — will take the helm of the combined company. Miles Pelham steps down as chairman, and the entire board gets replaced with directors nominated by Resulticks shareholders.

This is not a conventional acquisition; it's an inversion of power disguised as a public-company transaction. For investors, the calculus comes down to whether imported growth financed by ever-increasing share issuance can ultimately justify the dilution. The stock's recent behavior — hovering at 1.25 dollars against a prior close of 1.24 dollars — suggests traders are still trying to price that uncertainty.

Diginex's positioning in ESG and compliance software puts it squarely in a consolidation zone where smaller players struggle to scale organically and resort to buying whatever growth the market will fund. The appointment of Jan-Jaap Verhoeve as chief commercial officer to lead global sales strategy is a sensible move, though it does little to address the structural question of how the company escapes its dilution spiral.

For existing shareholders, the answer won't come from the revenue curve. It will come from the negotiating table — and from the vote on October 8, when they decide whether 14 percent of something larger is worth more than 100 percent of what they currently hold.